"Super testing" conducted early in this year's Arlington Park meet resulted in 26 positives for prednisone but found no evidence of other prohibited substances, according to the Illinois Racing Board.
Therapeutic medications will be the focus of the next round of "Super-Testing," the results of which should be available the first week of December during the University of Arizona Symposium on Racing. More than 500 blind samples remain to be tested for Class 4 medications.
More than 700 samples have been reviewed through the National Thoroughbred Racing Association's "super testing" program, with another 1,100 on the way before an Aug. 1 deadline. But in the absence of national equine medication rules, the "calling of positives" will depend upon the jurisdiction.
In a letter to the National Thoroughbred Racing Association, a group of chemists and veterinarians who form the Testing Integrity Program has warned that "super testing," as it is called, could create a public relations nightmare for the racing industry should the betting public believe use of illegal medications is rampant.
Most Popular Stories
- Frosted Continues Working Toward Belmont
- Agency Selected to Market American Pharoah
- Pletcher Horses Top Belmont Work Tab
- Hail Hooper, Hyperion
- Frosted Scheduled for Belmont Stakes Run
- Gleneagles to Try for Guineas Double
- Commentary: Unintended Consequences
- Geller to Follow Loiselle on Woodbine Mic
- American Pharoah Back on Track at Churchill
- American Pharoah to Stand at Ashford Stud